A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

被引:44
作者
van Baal, Pieter [1 ]
Perry-Duxbury, Meg [1 ]
Bakx, Pieter [1 ]
Versteegh, Matthijs [2 ]
van Doorslaer, Eddy [1 ,3 ]
Brouwer, Werner [1 ]
机构
[1] Erasmus Univ, Erasmus Sch Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[3] Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands
关键词
Bayesian statistics; cost-effectiveness analysis; opportunity costs; threshold; HEALTH; NETHERLANDS; OUTCOMES; DEATH; LIFE;
D O I
10.1002/hec.3831
中图分类号
F [经济];
学科分类号
02 ;
摘要
Traditionally, threshold levels of cost-effectiveness have been derived from willingness-to-pay studies, indicating the consumption value of health (v-thresholds). However, it has been argued that v-thresholds need to be supplemented by so-called k-thresholds, which are based on the marginal returns to health care. The objective of this research is to estimate a k-threshold based on the marginal returns to cardiovascular disease (CVD) hospital care in the Netherlands. To estimate a k-threshold for hospital care on CVD, we proceed in two steps: First, we estimate the impact of hospital spending on mortality using a Bayesian regression modelling framework, using data on CVD mortality and CVD hospital spending by age and gender for the period 1994-2010. Second, we use life tables in combination with quality of life data to convert these estimates into a k-threshold expressed in euros per quality-adjusted life year gained. Our base case estimate resulted in an estimate of 41,000 per quality-adjusted life year gained. In our sensitivity analyses, we illustrated how the incorporation of prior evidence into the estimation pushes estimates downwards. We conclude that our base case estimate of the k-threshold may serve as a benchmark value for decision making in the Netherlands as well as for future research regarding k-thresholds.
引用
收藏
页码:87 / 100
页数:14
相关论文
共 47 条
  • [1] [Anonymous], HDB HLTH EC
  • [2] SOME TESTS OF SPECIFICATION FOR PANEL DATA - MONTE-CARLO EVIDENCE AND AN APPLICATION TO EMPLOYMENT EQUATIONS
    ARELLANO, M
    BOND, S
    [J]. REVIEW OF ECONOMIC STUDIES, 1991, 58 (02) : 277 - 297
  • [3] Inquiry into the Relationship between Equity Weights and the Value of the QALY
    Bobinac, Ana
    van Exel, N. Job A.
    Rutten, Frans F. H.
    Brouwer, Werner B. F.
    [J]. VALUE IN HEALTH, 2012, 15 (08) : 1119 - 1126
  • [4] Brouwer W., 2009, BASIS PAKKET URGENTE
  • [5] Claxton K., 2010, Appropriate Perspectives for Health Care Decisions
  • [6] Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
    Claxton, Karl
    Martin, Steve
    Soares, Marta
    Rice, Nigel
    Spackman, Eldon
    Hinde, Sebastian
    Devlin, Nancy
    Smith, Peter C.
    Sculpher, Mark
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (14) : 1 - +
  • [7] CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?
    Claxton, Karl
    Sculpher, Mark
    Palmer, Stephen
    Culyer, Anthony J.
    [J]. HEALTH ECONOMICS, 2015, 24 (01) : 1 - 7
  • [8] DISCOUNTING AND DECISION MAKING IN THE ECONOMIC EVALUATION OF HEALTH-CARE TECHNOLOGIES
    Claxton, Karl
    Paulden, Mike
    Gravelle, Hugh
    Brouwer, Werner
    Culyer, Anthony J.
    [J]. HEALTH ECONOMICS, 2011, 20 (01) : 2 - 15
  • [9] The lifetime costs and benefits of medical technology
    Cutler, David M.
    [J]. JOURNAL OF HEALTH ECONOMICS, 2007, 26 (06) : 1081 - 1100
  • [10] THE INFLUENCE OF COST-EFFECTIVENESS AND OTHER FACTORS ON NICE DECISIONS
    Dakin, Helen
    Devlin, Nancy
    Feng, Yan
    Rice, Nigel
    O'Neill, Phill
    Parkin, David
    [J]. HEALTH ECONOMICS, 2015, 24 (10) : 1256 - 1271